Clinical trials recruiting for Stage IIIA Lung Cancer AJCC v8
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Carboplatin | 2 |
| Durvalumab | 2 |
| Paclitaxel | 2 |
| Pembrolizumab | 2 |
| Canakinumab | 1 |
| Cisplatin | 1 |
| Cyclophosphamide | 1 |
| Gemcitabine | 1 |
| Gemcitabine Hydrochloride | 1 |
| Infliximab | 1 |
| Nab-paclitaxel | 1 |
| Neoantigen Peptide Vaccine | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Texas | 6 |
| Florida | 3 |
| Illinois | 3 |
| New York | 3 |
| Arkansas | 2 |
| California | 2 |
| Colorado | 2 |
| Connecticut | 2 |
| Delaware | 2 |
| Georgia | 2 |
| Hawaii | 2 |
| Idaho | 2 |
Top cities
Self-screener
Recruiting trials
- Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial
- Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation
- Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers
- Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy
- Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
- Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
- Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study
- Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Related conditions
Trials recruiting for Stage IIIA Lung Cancer AJCC v8 often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Stage IIIA Lung Cancer AJCC v8 trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.